scholarly article | Q13442814 |
P2093 | author name string | B Y Rubin | |
H W Murray | |||
R B Roberts | |||
K Welte | |||
R Mertelsmann | |||
J L Jacobs | |||
P2860 | cites work | Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity | Q24683640 |
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS | Q29614260 | ||
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome | Q33821969 | ||
Decreased expression of human class II antigens on monocytes from patients with acquired immune deficiency syndrome. Increased expression with interferon-gamma | Q34622269 | ||
Clearance rates and systemic effects of intravenously administered interleukin 2 (IL-2) containing preparations in human subjects | Q36047402 | ||
Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity | Q36348121 | ||
Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine | Q36992102 | ||
Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture | Q37016535 | ||
Macrophages as effector cells of protective immunity in murine schistosomiasis: macrophage activation in mice vaccinated with radiation-attenuated cercariae | Q37084701 | ||
Activation of macrophages for microbicidal and tumoricidal effector functions by soluble factors from EL-4, a continuous T cell line | Q37112674 | ||
Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon | Q37564045 | ||
Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication. | Q37906618 | ||
AIDS — An Immunologic Reevaluation | Q40078470 | ||
UCLA conference. Interferon: immunobiology and clinical significance | Q40102031 | ||
Recent advances in the phenotypic and functional analysis of human T lymphocytes | Q40112021 | ||
T-cell growth factor | Q40293133 | ||
Human T-lymphocyte growth factor: regulation of growth and function of T lymphocytes. | Q40298599 | ||
Molecular characterization of interleukin 2. | Q40330090 | ||
T cell growth factor: parameters of production and a quantitative microassay for activity | Q40680131 | ||
In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2. | Q40821886 | ||
Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2 | Q41539473 | ||
Interferonlike factors from antigen- and mitogen-stimulated human leukocytes with antirickettsial and cytolytic actions on Rickettsia prowazekii. Infected human endothelial cells, fibroblasts, and macrophages | Q41854594 | ||
Response of resting human peripheral blood natural killer cells to interleukin 2. | Q42153962 | ||
Activation of human macrophages. Comparison of other cytokines with interferon-gamma | Q42232581 | ||
Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses | Q45807835 | ||
Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages | Q47982109 | ||
Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. | Q54467785 | ||
Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production | Q67246854 | ||
Defective in vitro T cell colony formation in the acquired immunodeficiency syndrome | Q69863721 | ||
Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism | Q69937749 | ||
The anticellular and protein-inducing activities of human gamma interferon preparations are mediated by the interferon | Q70425115 | ||
Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets | Q70428566 | ||
Purified human interleukin-2 enhances induction of immune interferon | Q70440651 | ||
Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome | Q70468096 | ||
Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes | Q70486953 | ||
Effect of murine interferon gamma on murine toxoplasmosis | Q70507351 | ||
OKT8 antibody inhibits OKT3-induced IL 2 production and proliferation in OKT8+ cells | Q70995882 | ||
Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correction by interleukin 2 | Q70999188 | ||
Cloned lines on interleukin 2 producer human T lymphocytes | Q72117579 | ||
Human recombinant interleukin-2 partly reconstitutes deficient in-vitro immune responses of lymphocytes from patients with AIDS | Q72575896 | ||
Interleukin 2 regulates immune interferon (IFN gamma) production by normal and suppressor cell cultures | Q72659878 | ||
Interleukin 2 regulation of mitogen induction of immune interferon (IFN gamma) in spleen cells and thymocytes | Q72662469 | ||
Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor | Q72715109 | ||
Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2 | Q72736387 | ||
Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects | Q72736404 | ||
Cellular origin of interleukin 2 (IL 2) in man: evidence for stimulus-restricted IL 2 production by T4+ and T8+ T lymphocytes | Q72762911 | ||
Immunologic effects of interleukin 2 in primary immunodeficiency diseases | Q72785416 | ||
Depressed interleukin 2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes | Q72820236 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1959-1964 | |
P577 | publication date | 1985-11-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome | |
P478 | volume | 76 |